Literature DB >> 23949591

Gonococcal susceptibility to cephalosporins--Hawaii, 2003 to 2011.

Sarah Kidd1, Maria V C Lee, Eloisa Maningas, Alan Komeya, Gail Kunimoto, Norman O'Connor, Alan R Katz, Glenn M Wasserman, Robert D Kirkcaldy, A Christian Whelen.   

Abstract

Among gonococcal isolates examined at the Hawaii State Laboratory Division from 2003 to 2011, the prevalence of elevated cefixime minimum inhibitory concentrations (MICs; ≥0.064 μg/mL) and elevated cefpodoxime MICs (≥0.19 μg/mL) increased over time. In contrast, few isolates exhibited elevated ceftriaxone MICs (≥0.094 μg/mL), and the prevalence of elevated ceftriaxone MICs did not change.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23949591      PMCID： PMC4580131          DOI： 10.1097/01.olq.0000431357.18959.30

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN： 0148-5717            Impact factor:   2.830


  9 in total

1.  Multidrug-resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime-Hawaii, 2001.

Authors:  Susan A Wang; Maria Veneranda C Lee; Norman O'Connor; Christopher J Iverson; Roy G Ohye; Peter M Whiticar; Judith A Hale; David L Trees; Joan S Knapp; Paul V Effler; Hillard S Weinstock
Journal:  Clin Infect Dis       Date:  2003-08-28       Impact factor: 9.079

2.  Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones.

Authors:  Masayasu Ito; Mitsuru Yasuda; Shigeaki Yokoi; Shin-ichi Ito; Yoshito Takahashi; Satoshi Ishihara; Shin-ichi Maeda; Takashi Deguchi
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

3.  Epidemiology and treatment of penicillinase-producing Neisseria gonorrhoeae.

Authors:  P L Perine; R S Morton; P Piot; M S Siegel; G M Antal
Journal:  Sex Transm Dis       Date:  1979 Apr-Jun       Impact factor: 2.830

4.  Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-08-10       Impact factor: 17.586

5.  Neisseria gonorrhoeae with high-level resistance to azithromycin: case report of the first isolate identified in the United States.

Authors:  Alan R Katz; Alan Y Komeya; Olusegun O Soge; Mandy I Kiaha; Maria Veneranda C Lee; Glenn M Wasserman; Eloisa V Maningas; A Christian Whelen; Robert D Kirkcaldy; Steven J Shapiro; Gail A Bolan; King K Holmes
Journal:  Clin Infect Dis       Date:  2011-12-19       Impact factor: 9.079

6.  Infections due to penicillinase-producing Neisseria gonorrhoeae in the United States: 1976-1980.

Authors:  H W Jaffe; J W Biddle; S R Johnson; P J Wiesner
Journal:  J Infect Dis       Date:  1981-08       Impact factor: 5.226

7.  Gonococcal resistance: are cephalosporins next?

Authors:  Robert D Kirkcaldy; Ronald C Ballard; Deborah Dowell
Journal:  Curr Infect Dis Rep       Date:  2011-04       Impact factor: 3.725

8.  Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-04-13       Impact factor: 17.586

9.  A remarkable reduction in the susceptibility of Neisseria gonorrhoeae isolates to cephems and the selection of antibiotic regimens for the single-dose treatment of gonococcal infection in Japan.

Authors:  Masatoshi Tanaka; Hiroshi Nakayama; Hiroaki Tunoe; Toshihisa Egashira; Akiko Kanayama; Takeshi Saika; Intetsu Kobayashi; Seiji Naito
Journal:  J Infect Chemother       Date:  2002-03       Impact factor: 2.211
  9 in total
  4 in total

1.  Emerging Trends in Antibiotic Resistant Neisseria gonorrhoeae: A National and Hawai'i Perspective.

Authors:  Alan R Katz; Alan Y Komeya; Jo M Dewater; Juval E Tomas; Lance Chinna; Glenn M Wasserman
Journal:  Hawaii J Health Soc Welf       Date:  2020-03-01

2.  Trends in Neisseria gonorrhoeae Susceptibility to Cephalosporins in the United States, 2006-2014.

Authors:  Robert D Kirkcaldy; Edward W Hook; Olusegun O Soge; Carlos del Rio; Grace Kubin; Jonathan M Zenilman; John R Papp
Journal:  JAMA       Date:  2015-11-03       Impact factor: 56.272

3.  Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016.

Authors:  Alan R Katz; Alan Y Komeya; Robert D Kirkcaldy; A Christian Whelen; Olusegun O Soge; John R Papp; Ellen N Kersh; Glenn M Wasserman; Norman P O'Connor; Pamela S O'Brien; Douglas T Sato; Eloisa V Maningas; Gail Y Kunimoto; Juval E Tomas
Journal:  Clin Infect Dis       Date:  2017-09-15       Impact factor: 9.079

4.  Antimicrobial Resistance in Neisseria gonorrhoeae: Proceedings of the STAR Sexually Transmitted Infection-Clinical Trial Group Programmatic Meeting.

Authors:  Anthony D Cristillo; Claire C Bristow; Elizabeth Torrone; Jo-Anne Dillon; Robert D Kirkcaldy; Huan Dong; Yonatan H Grad; Robert A Nicholas; Peter A Rice; Kenneth Lawrence; David Oldach; William Maurice Shafer; Pei Zhou; Teodora E Wi; Sheldon R Morris; Jeffrey D Klausner
Journal:  Sex Transm Dis       Date:  2019-03       Impact factor: 2.830
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.